NM
Neumora Therapeutics, Inc. Common Stock (NMRA)
NASDAQ·Healthcare·Biotechnology
$0.37
-6.53%
Mkt Cap $69.16M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (14 analysts)
$4.50
Range $4.00 – $5.00
Implied Upside
+1122.5%
Consensus $4.50 vs current $0.37